Retinoblastoma: Abnormal gadolinium enhancement of anterior segment of eyes at MR imaging with clinical and histopathologic correlation

Radiology

Volumn 228, Issue 3, 2003, Pages 683-690

  Galluzzi, Paolo ^a   Cerase, Alfonso ^a   Hadjistilianou, Theodora ^a   De Francesco, Sonia ^a   Toti, Paolo ^a   Vallone, Ignazio Maria ^a   Filosomi, Giuseppe ^a   Monti, Lucia ^a   Bracco, Sandra ^a   Gennari, Paola ^a   Ginanneschi, Chiara ^a   Venturi, Carlo ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Eye; MR; Neoplasms; Retina

Indexed keywords

GADOLINIUM;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ANTERIOR EYE SEGMENT; ARTICLE; CANCER INVASION; CHILD; CHOROID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ENUCLEATION; EVALUATION; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; RETINOBLASTOMA; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANTERIOR CHAMBER; CHILD, PRESCHOOL; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; INFANT; INFANT, NEWBORN; INTRAOCULAR PRESSURE; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; SENSITIVITY AND SPECIFICITY;

EID: 0041930650     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2283020466     Document Type: Article

References (55)

1. Abramson DH. Retinoblastoma 1990: diagnosis, treatment, and implications. Paediatr Ann 1990; 19:387-395.
2. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus 2000; 37:134-141.
3. Messmer EP, Heinrich T, Hopping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991; 98: 136-141.
4. Haik BG, Dunleavy SA, Cooke C, et al. Retinoblastoma with anterior chamber extension. Ophthalmology 1987; 94:367-370.
5. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology 1989; 96:217-222.
6. Tosi P, Cintorino M, Toti P, et al. Histopathological evaluation for the prognosis of retinoblastoma. Ophthalmic Paediatr Genet 1989; 10:173-177.
7. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 1993; 77:544-548.
8. Baez KA, Ulbig MW, Cater J, Shields CL, Shields JA. Iris neovascularization, increased intraocular pressure and vitreous hemorrhage as risk factors for invasion of the optic nerve and choroid in children with retinoblastoma. Ophthalmologe 1994; 91:796-800.
9. Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer 1994; 73:692-698.
10. Karcioglu XA, Gordon RA, Karcioglu GL. Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology 1985; 92: 1763-1767.
11. Shields JA, Shields CL. Differentiation of Coats' disease and retinoblastoma. J Pediatr Ophthalmol Strabismus 2001; 38:262-266.
12. Roth DB, Scott IU, Murray TG, et al. Echography of retinoblastoma: histopathologic correlation and serial evaluation after globe-conserving radiotherapy or chemotherapy. J Pediatr Ophthalmol Strabismus 2001; 38:136-143.
13. Mafee MF, Goldberg MF, Cohen SB, et al. Magnetic resonance imaging versus computed tomography of leucokoric eyes and use of in vivo proton magnetic resonance spectroscopy of retinoblastoma. Ophthalmology 1989; 23:144-147.
14. De Potter P, Flanders AE, Shields JA, Shields CL, Gonzales CF, Rao VM. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions. Arch Ophthalmol 1994; 112:340-348.
15. Smirniotopoulos JG, Bargallo N, Mafee MF. Differential diagnosis of leukokoria: radiologic-pathologic correlation. Radio-Graphics 1994; 14:1059-1079.
16. De Potter P, Shields JA, Shields CL. Tumors and pseudotumors of the retina. In: De Potter P, Shields JA, Shields CL, eds. MRI of the eye and orbit. Philadelphia, Pa: Lippincott, 1995; 93-116.
17. Atlas SW, Galetta SL. The orbit and visual system. In: Atlas SW, ed. Magnetic resonance imaging of the brain and spine. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 1996; 1018-1092.
18. Barkhof F, Smeets M, van der Valk P, et al. MR imaging in retinoblastoma. Eur Radiol 1997; 7:726-731.
19. Kaufman LM, Mafee MF, Song CD. Retinoblastoma and simulating lesions. Radiol Clin North Am 1998; 36:1101-1117.
20. Villablanca JP, Mafee MF, Kaufman LM, Greenwald M, Naidich TP. Facies to remember: retinoblastoma, Coats disease, and toxocariasis. Int J Neuroradiol 1998; 4:41-50.
21. Galluzzi P, Venturi C, Cerase A, et al. Coats disease: smaller volume of the affected globe. Radiology 2001; 221:64-69.
22. Shields JA, Shields CL, Suvarnamani C, et al. Retinoblastoma manifesting as orbital cellulitis. Am J Ophthalmol 1991; 112: 442-449.
23. Brisse HJ, Lumbroso L, Fréneaux PC, et al. Sonographic, CT, and MR imaging findings in diffuse infiltrative retinoblastoma: report of two cases with histologic comparison. AJNR Am J Neuroradiol 2001; 22:499-504.
24. Desjardins L, Levy C, Lumbroso L, et al. Current treatment of retinoblastoma: 153 children treated between 1995 and 1998. J Fr Ophtalmol 2000; 23:475-481. [French]
25. Imhof SM, Moll AC, Schouten-Van Meeteren AY. Intraocular retinoblastoma: new therapeutic options. Ned Tijdschr Geneeskd 2001; 145:2165-2170. [Dutch]
26. Moffat K, Blumenkranz MS, Hernandez E. The lens and rubeosis iridis: an angiographic study. Can J Ophthalmol 1984; 19:130-133.
27. Walton DS, Grant WM. Retinoblastoma and iris neovascularization. Am J Ophthalmol 1968; 65:598-599.
28. Spaulding AG. Rubeosis iridis in retinoblastoma and pseudoglioma. Trans Am Ophthalmol Soc 1978; 76:564-609.
29. Pe'er J, Neufeld M, Baras M, Gnessin H, Itin A, Keshet E. Rubeosis iridis in retinoblastoma: histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology 1997; 104:1251-1258.
30. Miyake T, Kayazawa F. Blood-aqueous barrier in eyes with retinal vein occlusion. Ophthalmology 1992; 99:906-910.
31. Nguyen NX, Kuchle M. Aqueous flare and cells in eyes with retinal vein occlusion: correlation with retinal fluorescein angiographic findings. Br J Ophthalmol 1993; 77:280-283.
32. Küchle M, Nguyen NX, Naumann GOH. Quantitative assessment of the blood-aqueous barrier in human eyes with malignant or benign uveal tumors. Am J Ophthalmol 1994; 117:521-528.
33. Moriarty AP, Spalton DJ, Moriarty BJ, Shilling JS, Ffytche TJ, Bulsara M. Studies of blood-aqueous barrier in diabetes mellitus. Aro J Ophthalmol 1994; 114:768-771.
34. Nguyen NX, Küchle M, Strunk W. Tyndallometrie zur verlaufskontrolle nach Jod-125-brachytherapie uvealer melanoma. Klin Monatsbl Augenheilkd 1996; 209:25-30.
35. Ino-ue M, Azumi A, Shirabe H, Yamamoto M. Iridopathy in eyes with proliferative diabetic retinopathy: detection of early stage of rubeosis iridis. Ophthalmologica 1998; 212:15-18.
36. Frank JA, Dwyer AJ, Girton M, et al. Opening of blood-ocular barrier demonstrated by contrast-enhanced MR imaging. J Comput Assist Tomogr 1986; 10: 912-916.
37. Kolodny NH, Freddo TF, Lawrence BA, Suarez C, Bartels S. Contrast-enhanced magnetic resonance imaging confirmation of an anterior protein pathway in normal rabbit eyes. Invest Ophthalmol Vis Sci 1996; 37:1602-1607.
38. Bert R, Freddo T, Caruthers SD, Jara H, Kolodny N, Melham ER. Confirmation of an anterior large-molecule diffusion pathway in the normal human eye. Invest Ophthalmol Vis Sci 1999; 40(suppl): S198.
39. Freddo TF. Shifting the paradigm of the blood-aqueous barrier. Exp Eye Res 2001; 73:581-592.
40. Manfrè L, Midiri M, Giuffrè G, et al. Blood-ocular barrier damage: use of contrast-enhanced MRI. Eur Radiol 1997; 7:110-114.
41. Chen CJ. Intraocular contrast enhancement in Adams pattern III hypoxic brain damage: MRI. Neuroradiology 2000; 42: 54-55.
42. Warwick R, Williams PL. The peripheral visual apparatus. Gray's anatomy. 35th ed. Philadelphia, Pa: Saunders, 1973; 1096-1122.
43. Mafee MF, Ainbinder D, Afshani E, Mafee RF. The eye. Neuroimaging Clin North Am 1996; 6:29-59.
44. Pavlin CJ, Foster FS. Ultrasound biomicroscopy: high-frequency ultrasound imaging of the eye at microscopic resolution. Radiol Clin North Am 1998; 36:1047-1058.
45. Bill A. Blood circulation and fluid dynamics in the eye. Physiol Rev 1975; 44:383-417.
46. Rapoport SI. Osmotic opening of blood-brain and blood-ocular barriers. Exp Eye Res 1977; 25(suppl):499-509.
47. Cunha-Vaz JG. The blood-retinal barriers. Doc Ophthalmol 1976; 41:287-327.
48. Bill A. The blood-aqueous barrier. Trans Ophthalmol Soc U K 1986; 105:149-155.
49. Noske W, Stamm CC, Hirsch M. Tight junctions of the human ciliary epithelium: regional morphology and implications on transepithelial resistance. Exp Eye Res 1994; 59:141-149.
50. Jacquemin C, Karcioglu ZA. Detection of optic nerve involvement in retinoblastoma with enhanced computed tomography. Eye 1998; 12:179-183.
51. Hayreh SS. Structure and blood supply of the optic nerve. In: Heilmann K, Richardson KT, eds. Glaucoma: conceptions of a disease. Philadelphia, Pa: Saunders, 1978; 78-103.
52. Orgul S, Cioffi GA. Embryology, anatomy and histology of the optic nerve vasculature. J Glaucoma 1996; 5:285-294.
53. Aiello LP, Avery RL, Arrig PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-1487.
54. Ehrenberg M, Mc Cuen BW II, Schindler RH, Machemer R. Preoperative iris fluorescein angiography and periocular steroids. Ophthalmology 1984; 91:321-325.
55. Ainbinder DJ, Haik BG, Frei DF, Gupta KL, Mafee MF. Gadolinium enhancement: improved MRI detection of retinoblastoma extension into the optic nerve. Neuroradiology 1996; 38:778-781.